NCT04990375View on ClinicalTrials.gov

tDCS to Prevent Relapse in Alcohol Use Disorder

NACompletedINTERVENTIONAL
Enrollment

40

Participants

Timeline

Start Date

April 2, 2021

Primary Completion Date

June 6, 2022

Study Completion Date

June 6, 2022

Conditions
Active tDCSSham tDCS
Interventions
DEVICE

tDCS

5 sessions of 20-minute tDCS at 2 mA over the dorsolateral prefrontal cortex (35cm² sponge)

Trial Locations (1)

1020

CHU-Brugmann, Brussels

All Listed Sponsors
lead

Brugmann University Hospital

OTHER

NCT04990375 - tDCS to Prevent Relapse in Alcohol Use Disorder | Biotech Hunter | Biotech Hunter